Recall

Par Health Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection Due to the Presence of Particulate Matter

Recall from a federal regulator

Headline as published by U.S. Food and Drug Administration (Recalls) on Sep 18, 2026; collected by the wire Oct 1, 2026, 7:45 PM ET.

Read at U.S. Food and Drug Administration (Recalls)

ROCHESTER, MI– September 18, 2026 –Par Health is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) to the hospital level. The product is being recalled due to the presence of particulate matter identified as cellulose or stopper materia

From U.S. Food and Drug Administration (Recalls)’s feed

Coverage

  1. U.S. Food and Drug Administration (Recalls) Federal regulators

    Par Health Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection Due to the Presence of Particulate Matter

Topics

Explore the named firms, organizations and MDL dockets above. Sources and method